EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieMultizentrische Studie

The outcomes of patients with septic shock treated with propafenone compared to amiodarone for supraventricular arrhythmias are related to end-systolic left atrial volume

Petr Waldauf, Michal Porizka, Jan Horejsek, Michal Otahal, Eva Svobodova, Ivana Jurisinova, Michal Maly, Tomas Brozek, Jan Rulisek, Pavel Trachta, Tomas Tencer, Adela Krajcova und 2 weitere

European Heart Journal: Acute Cardiovascular Care · 19.02.2024

DOI: 10.1093/ehjacc/zuae023 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, online erschienen am 19.02.2024. Verfasst von Petr Waldauf und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Intensive Care, 3rd Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, …. Hauptthemen laut MEDLINE: Propafenone, Amiodarone, Shock, Septic, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Gefördert von: Czech Health Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A recently published trial has shown no differences in outcomes between patients with new-onset supraventricular arrhythmia (SVA) in septic shock treated with either propafenone or amiodarone. However, these outcome data have not been evaluated in relation to the presence or absence of a dilated left atrium (LA).

Methods

Patients with SVA and a left ventricular ejection fraction ≥35% were randomized to receive intravenous propafenone (70mg bolus followed by 400-840mg/24h) or amiodarone (300mg bolus followed by 600-1800mg/24h). They were divided into groups based on whether their end-systolic left atrial volume (LAVI) was ≥40 ml/m². The subgroup outcomes assessed were survival at ICU discharge, 1-month, 3-months, 6-months, and 12-months.

Results

Propafenone cardioverted earlier (p=0.009) and with fewer recurrences (p=0.001) in the patients without LA enlargement (n=133). Patients with LAVI˂40ml/m2 demonstrated a mortality benefit of propafenone over the follow up of 1-year (Cox regression, HR 0.6 (95% CI 0.4; 0.9), p=0.014). Patients with dilated LA (n=37) achieved rhythm control earlier in amiodarone (p=0.05) with similar rates of recurrences (p=0.5) compared to propafenone. The outcomes for patients with LAVI≥40 ml/m2 were less favourable with propafenone compared to amiodarone at 1-month (HR 3.6 (95% CI 1.03; 12.5), p=0.045) however, it did not reach statistical significance at 1 year (HR 1.9 (95% CI 0.8; 4.4), p=0.138).

Conclusion

Patients with non-dilated LA who achieved rhythm control with propafenone in the setting of septic shock had better short-term and long-term outcomes than those treated with amiodarone, which seemed to be more effective in patients with LAVI≥40 ml/m².

Trial registration

ClinicalTrials.gov Identifier: NCT03029169, registered on 24th of January 2017

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PropafenoneAmiodaroneShock, SepticAnti-Arrhythmia AgentsHeart AtriaTachycardia, SupraventricularHumansMaleFemaleAgedTreatment OutcomeMiddle AgedStroke Volume

Stichwörter der Autor:innen

AmiodaroneAtrial fibrillationCardioversionPropafenoneSeptic shockSupraventricular arrhythmia

Substanzen

PropafenoneAmiodaroneAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Anaesthesiology and Intensive Care, 3rd Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital in Prague, Prague 10, Czechia.
  • Department of Anaesthesiology and Intensive Care, 1st Faculty of Medicine, Charles University and General University Hospital in Prague, U nemocnice 2, Prague 2, 12808, Czechia, EU.

ORCID-Profile: Martin Balik

Förderung

  • Czech Health Research Council

Zitieren

APA

Waldauf, P., Porizka, M., Horejsek, J., Otahal, M., Svobodova, E., Jurisinova, I., Maly, M., Brozek, T., Rulisek, J., Trachta, P., Tencer, T., Krajcova, A., Duska, F., & Balik, M. (2024). The outcomes of patients with septic shock treated with propafenone compared to amiodarone for supraventricular arrhythmias are related to end-systolic left atrial volume. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuae023

Vancouver

Waldauf P, Porizka M, Horejsek J, Otahal M, Svobodova E, Jurisinova I, et al. The outcomes of patients with septic shock treated with propafenone compared to amiodarone for supraventricular arrhythmias are related to end-systolic left atrial volume. European Heart Journal: Acute Cardiovascular Care. 2024. doi:10.1093/ehjacc/zuae023

BibTeX
@article{Waldauf2024,
  author = {Waldauf, Petr and Porizka, Michal and Horejsek, Jan and Otahal, Michal and Svobodova, Eva and Jurisinova, Ivana and Maly, Michal and Brozek, Tomas and Rulisek, Jan and Trachta, Pavel and Tencer, Tomas and Krajcova, Adela and Duska, Frantisek and Balik, Martin},
  title = {The outcomes of patients with septic shock treated with propafenone compared to amiodarone for supraventricular arrhythmias are related to end-systolic left atrial volume},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2024},
  doi = {10.1093/ehjacc/zuae023}
}
Kostenlos starten →